GLP-1 receptor agonist

Semaglutide clinical trials

Answer

Semaglutide has 861 registered trials: 348 running, 347 completed, 24 stopped early. 109 posted results.

Trial registerClinicalTrials.gov and EU CTIS, read 2026-10-03

TrialTitleStatusPhaseRegisteredResults
NCT06856291
Trial register
Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistancecompleted-2025-03-04-
NCT06977438
Trial register
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forwardnot yet recruiting participants-2025-05-18-
NCT07855133
Trial register
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From not yet recruiting participants12026-10-02-
2022-502922-41-00
Trial register
Long-term safety and efficacy of semaglutide s.c. once-weekly on weight management in children and adolescents (aged 6 to <18 years) with obesity or overweightNot stated3--
NCT05254314
Trial register
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)running, but no longer enrolling-2022-02-24-
NCT06184633
Trial register
DUTCH Weight Control in Atrial Fibrillation Studyrunning, but no longer enrolling-2023-12-28-
NCT07112872
Trial register
A Study to Compare Different Doses of RO7795081 With Placebo or Semaglutide in People With Type 2 Diabetesrunning, but no longer enrolling-2025-08-08-
NCT07249554
Trial register
Combination Therapy for Alcohol Use Disordernot yet recruiting participants-2025-11-25-
NCT07820358
Trial register
Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancernot yet recruiting participants22026-09-15-
2026-527373-11-00
Trial register
SEMAGONA: A randomized four-arm parallel group double-blind double dummy 52-week clinical trial comparing the effects of s.c. Semaglutide 2.4 mg once-weekly, i.Not stated2--
NCT03596450
Trial register
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pcompleted-2018-07-23Posted
NCT05567796
Trial register
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weightrunning, but no longer enrolling-2022-10-05-
NCT06323174
Trial register
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercisecompleted-2024-03-21-
NCT06854614
Trial register
Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)running, but no longer enrolling42025-03-03-
NCT07011667
Trial register
A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termrunning, but no longer enrolling-2025-06-09-
NCT07253285
Trial register
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weightcurrently recruiting participants-2025-11-28-
NCT07280221
Trial register
WEgovy Real World Assessment of Weight Loss in Koreaenrolling by invitation only-2025-12-12-
NCT07564414
Trial register
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Loscurrently recruiting participants-2026-05-04-
NCT07817251
Trial register
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisemacurrently recruiting participants32026-09-14-
NCT07849348
Trial register
Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney not yet recruiting participants-2026-09-30-
NCT07850765
Trial register
Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Marketscompleted-2026-09-30-
2023-506827-26-00
Trial register
Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS)Not stated3--
NCT05305794
Trial register
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"currently recruiting participants-2022-03-31-
NCT06771115
Trial register
Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesitycompleted-2025-01-13Posted
NCT07171723
Trial register
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatmentcompleted-2025-09-12-
NCT07724340
Trial register
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweighrunning, but no longer enrolling-2026-07-24-
NCT07845500
Trial register
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesitynot yet recruiting participants32026-09-29-
NCT07845578
Trial register
A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weightnot yet recruiting participants12026-09-29-
NCT07845994
Trial register
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharynot yet recruiting participants32026-09-29-
NCT06260722
Trial register
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 running, but no longer enrolling32024-02-15-
NCT07668414
Trial register
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutidecurrently recruiting participants-2026-06-25-
NCT07797036
Trial register
Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitusnot yet recruiting participants22026-09-01-
NCT07819227
Trial register
Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutidecompleted22026-09-14-
NCT06738979
Trial register
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjectscompleted-2024-12-18-
NCT07254715
Trial register
Effect of Itopride on Semaglutide Gastroparesiscompleted-2025-11-28-
NCT07840729
Trial register
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participantsnot yet recruiting participants12026-09-25-
NCT06131372
Trial register
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSemacompleted-2023-11-14-
NCT07511543
Trial register
Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomynot yet recruiting participants-2026-04-06-
2024-514906-30-00
Trial register
TOLEDDO: Effect of weekly GLP1 agonist treatment in "double diabetes": a randomized, open-label studyNot stated3--
NCT07651319
Trial register
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Diseasecurrently recruiting participants-2026-06-16-
NCT07836140
Trial register
A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.completed22026-09-23-
2023-506289-29-00
Trial register
eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity)Not stated4--
2024-513168-24-00
Trial register
A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight loss in people livinNot stated2--
NCT06050577
Trial register
The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trialrunning, but no longer enrolling-2023-09-22-
NCT06173778
Trial register
Semaglutide for Post-Smoking Cessation Weight Managementcurrently recruiting participants-2023-12-18-
NCT07163624
Trial register
UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Studycompleted-2025-09-09-
NCT07218354
Trial register
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)currently recruiting participants-2025-10-20-
NCT07390110
Trial register
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)completed-2026-02-05-
NCT05714683
Trial register
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitunot yet recruiting participants-2023-02-06-
NCT06779929
Trial register
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetescompleted-2025-01-17-
NCT07169136
Trial register
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)currently recruiting participants-2025-09-11-
NCT07423481
Trial register
Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesitynot yet recruiting participants-2026-02-20-
NCT07627191
Trial register
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancercurrently recruiting participants-2026-06-04-
NCT07220629
Trial register
Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)completed-2025-10-24-
NCT06913023
Trial register
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitusnot yet recruiting participants-2025-04-06-
NCT07639021
Trial register
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesityrunning, but no longer enrolling-2026-06-10-
NCT05569772
Trial register
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetescurrently recruiting participants-2022-10-06-
NCT06045221
Trial register
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformincompleted-2023-09-21Posted
NCT07820111
Trial register
Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trialcompleted32026-09-15-
NCT06897475
Trial register
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatidecurrently recruiting participants22025-03-27-
NCT06908694
Trial register
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapyrunning, but no longer enrolling-2025-04-03-
NCT07653477
Trial register
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUcurrently recruiting participants-2026-06-17-
NCT07415954
Trial register
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetescurrently recruiting participants-2026-02-17-
NCT07668388
Trial register
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetescurrently recruiting participants-2026-06-25-
NCT06691243
Trial register
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIVrunning, but no longer enrolling-2024-11-15-
NCT06797869
Trial register
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathycompleted-2025-01-29-
NCT06836284
Trial register
The Evira Study: Additional Support During Obesity Treatmentcurrently recruiting participants-2025-02-20-
NCT07010432
Trial register
The Role of the Amylin Analogue Cagrilintide in Bone Metabolismcurrently recruiting participants-2025-06-08-
NCT07184086
Trial register
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Dietrunning, but no longer enrolling-2025-09-19-
NCT07223983
Trial register
Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)running, but no longer enrolling-2025-11-03-
NCT07812597
Trial register
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)not yet recruiting participants22026-09-10-
2026-526951-79-00
Trial register
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Semaglutide Subcutaneous Depot (CAM2056) in People with ObesNot stated2--
NCT03811561
Trial register
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetesrunning, but no longer enrolling-2019-01-22-
NCT05202353
Trial register
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liverrunning, but no longer enrolling-2022-01-21-
NCT05726227
Trial register
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weightrunning, but no longer enrolling-2023-02-13-
NCT06323161
Trial register
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Icompleted-2024-03-21-
NCT06534411
Trial register
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLcompleted32024-08-02-
NCT07282613
Trial register
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetescurrently recruiting participants-2025-12-15-
NCT07662213
Trial register
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treatcurrently recruiting participants-2026-06-23-
NCT07770841
Trial register
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weightcurrently recruiting participants-2026-08-18-
NCT07801820
Trial register
Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellituscurrently recruiting participants22026-09-03-
2023-506924-94-00
Trial register
The cardiovascular safety and efficacy of cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) once-weekly in parNot stated3--
2023-509176-42-00
Trial register
Efficacy, safety and pharmacokinetics of cagrilintide s.c. 2.4 mg as monotherapy and in combination with semaglutide s.c. 2.4 mg (CagriSema) once weekly for weiNot stated3--
2025-523414-89-00
Trial register
Effects of semaglutide as add-on therapy to sulfonylurea on plasma glucose in individuals with HNF1A- and HNF4A-MODY - A Steno MODERN-MODY project (MM-SEMA)Not stated2--
2026-527538-29-00
Trial register
SemenGlutide: A randomized double-blinded, placebo-controlled, single-center, clinical trial comparing the effects of s.c. Semaglutide 2.4 mg once-weekly versusNot stated2--
NCT07059377
Trial register
Semaglutide for Smoking Cessation in Patients With Diabetescurrently recruiting participants-2025-07-10-
2026-526083-20-00
Trial register
A research study looking into how a high dose of s.c. semaglutide works with emptying of the stomach in people with excess body weightNot stated1--
NCT04822181
Trial register
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)running, but no longer enrolling-2021-03-30-
NCT06221969
Trial register
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin Withcompleted32024-01-24-
NCT06851962
Trial register
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.completed-2025-02-28-
NCT07446998
Trial register
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Lossrunning, but no longer enrolling-2026-03-03-
NCT07627074
Trial register
Weight Loss in Adults Using Semaglutide (Real-world Study)completed-2026-06-04-
NCT07745504
Trial register
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weightcurrently recruiting participants-2026-08-04-
NCT07767175
Trial register
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesitycurrently recruiting participants-2026-08-17-
2023-503753-35-01
Trial register
FIT-HF - Effect of weight loss on physical and cardiac performance in patients with heart failure and obesityNot stated2--
NCT06803888
Trial register
Bariatric Surgery vs. Semaglutide vs. Tirzepatiderunning, but no longer enrolling42025-01-31-
2026-525465-42-00
Trial register
Efficacy and safety of once-weekly subcutaneous UBT251 in participants with type 2 diabetes - a dose-finding studyNot stated2--
NCT06015893
Trial register
Semaglutide Therapy for Alcohol Reduction (STAR)running, but no longer enrolling-2023-08-29-
NCT06762314
Trial register
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetescompleted-2025-01-07-
NCT06934655
Trial register
Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youthcurrently recruiting participants-2025-04-18-
NCT06299098
Trial register
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weigrunning, but no longer enrolling-2024-03-07-
NCT07284979
Trial register
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetescurrently recruiting participants-2025-12-16-
NCT07677995
Trial register
Free Fatty Acid Effects In Type 2 Diabetesenrolling by invitation only-2026-07-01-
NCT05669755
Trial register
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vesselsrunning, but no longer enrolling-2023-01-03-
NCT05819853
Trial register
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndromecurrently recruiting participants-2023-04-19-
NCT06401746
Trial register
Body Surface Gastric Mapping in Patients on Semaglutidecompleted-2024-05-07Posted
NCT06716307
Trial register
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweicompleted-2024-12-04-
NCT06548490
Trial register
GLP-1R Agonist Treatment for Opioid Use Disordercurrently recruiting participants-2024-08-12-
NCT07760948
Trial register
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutidenot yet recruiting participants-2026-08-12-
2023-504159-29-01
Trial register
Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantationNot stated2--
NCT07787936
Trial register
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registrynot yet recruiting participants-2026-08-18-
2024-520446-31-00
Trial register
Efficacy and safety of NNC0487-0111 s.c. once-weekly compared to semaglutide s.c. once-weekly in participants with overweight or obesity, and type 2 diabetes (ANot stated3--
NCT07783854
Trial register
A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesitynot yet recruiting participants-2026-08-25-
NCT07781371
Trial register
A Retrospective Real-World Cohort Studynot yet recruiting participants-2026-08-19-
2025-523260-20-00
Trial register
Protocol Title: Efficacy and safety of once-weekly subcutaneous NNC0662-0419 in participants with type 2 diabetes - a dose-finding studyNot stated2--
NCT04596631
Trial register
A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetescompleted-2020-10-22Posted
NCT07779343
Trial register
OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programmecurrently recruiting participants-2026-08-21-
2024-518682-95-00
Trial register
SIGNAL - Body fluid proteome SIGnatures for persoNALised intervention to prevent cardiovascular and renal complications in diabetesNot stated4--
NCT07485062
Trial register
Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetesnot yet recruiting participants-2026-03-20-
NCT07563699
Trial register
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellituscurrently recruiting participants-2026-05-04-
NCT06546384
Trial register
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Diseasenot yet recruiting participants-2024-08-09-
NCT06807970
Trial register
Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonistrunning, but no longer enrolling-2025-02-04-
NCT07213323
Trial register
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatmentcurrently recruiting participantsNA2025-09-18-
NCT07772960
Trial register
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomesnot yet recruiting participants-2026-08-19-
2025-523511-11-00
Trial register
A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus SeNot stated3--
2026-526016-36-00
Trial register
A neuropsychobiological approach to optimize patient selection for GLP-1-based pharmacotherapy for weight management across the binge eating spectrumNot stated4--
NCT05891496
Trial register
A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Diseasecompleted-2023-06-07Posted
NCT07770152
Trial register
Semaglutide in Youth With Autism Spectrum Disordernot yet recruiting participants-2026-08-18-
NCT07770282
Trial register
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndromenot yet recruiting participants-2026-08-18-
NCT07202247
Trial register
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients Ducurrently recruiting participants22025-10-01-
NCT07769047
Trial register
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitornot yet recruiting participants-2026-08-17-
NCT05132088
Trial register
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesitycompleted-2021-11-24Posted
NCT05371496
Trial register
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fractioncompleted-2022-05-12-
2023-506962-30-00
Trial register
The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitisNot stated3--
2025-524626-18-00
Trial register
Efficacy and safety of once daily oral semaglutide in adults with overweight or obesityNot stated3--
NCT05220917
Trial register
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Studyrunning, but no longer enrolling-2021-12-22-
NCT06269120
Trial register
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Tycompleted-2024-02-21-
NCT07087795
Trial register
A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetesrunning, but no longer enrolling-2025-07-28-
NCT07271251
Trial register
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People Wicompleted-2025-12-09-
NCT05040087
Trial register
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)running, but no longer enrolling-2021-08-27-
NCT07760532
Trial register
Comparing Facial Aging Between Identical Twins With 3D Imagingnot yet recruiting participants-2026-08-07-
NCT07178145
Trial register
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fractioncurrently recruiting participants-2025-07-23-
NCT07728669
Trial register
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapycurrently recruiting participants-2026-07-22-
NCT03884075
Trial register
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)currently recruiting participants-2019-03-21-
NCT05035082
Trial register
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)completed-2021-09-05Posted
NCT07275697
Trial register
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Studycurrently recruiting participants-2025-12-10-
NCT07466017
Trial register
A Study of CS060380 Tablets in Patients With MASH and Obesityrunning, but no longer enrolling-2026-03-12-
NCT07754045
Trial register
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adultsnot yet recruiting participants-2026-08-10-
NCT07755085
Trial register
GLP-1s in Hip and Knee Arthroplastynot yet recruiting participants-2026-08-03-
2025-523933-24-00
Trial register
A Randomized, Open-label, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Oral Semaglutide in AdNot stated3--
NCT05984238
Trial register
A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapycompleted-2023-08-09-
2025-522488-14-00
Trial register
A clinical study to compare efficacy and safety of two different doses of CagriSema and semaglutide in participants with obesity with or without type 2 diabetesNot stated3--
NCT06411210
Trial register
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatmentcurrently recruiting participants-2024-05-13-
NCT06715514
Trial register
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetesrunning, but no longer enrolling-2024-11-28-
NCT07055607
Trial register
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practiceenrolling by invitation only-2025-07-09-
NCT07743983
Trial register
A Study of BGM0504 in Early T2DM With Obesitycurrently recruiting participants-2026-08-04-
2023-509600-15-00
Trial register
Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) 1.0 mg/1.0 mg s.c. once weekly versus tirzepatide 5 mg s.c. once weekly in partiNot stated3--
NCT05548647
Trial register
Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effectscompleted-2022-09-21Posted
NCT07428746
Trial register
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetescurrently recruiting participants-2026-02-24-
NCT06374875
Trial register
Fibrosis Lessens After Metabolic Surgerycurrently recruiting participants42024-04-16-
NCT07478653
Trial register
MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Diseasenot yet recruiting participants-2026-03-12-
NCT07673900
Trial register
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participantscurrently recruiting participants-2026-06-29-
NCT07740291
Trial register
Tirzepatide Impact Assessment Studycurrently recruiting participantsNA2026-07-31-
NCT06649344
Trial register
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2completed-2024-10-18-
NCT07737522
Trial register
Myocardial Metabolic Flux in Pulmonary Arterial Hypertensionnot yet recruiting participants-2026-07-27-
NCT07732738
Trial register
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.currently recruiting participants-2026-07-19-
NCT07731256
Trial register
Semaglutide for Low Back Painnot yet recruiting participants-2026-07-28-
NCT07732218
Trial register
Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trialcompleted-2026-07-28-
NCT07732426
Trial register
Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendenciescurrently recruiting participants-2026-07-28-
2022-501392-81-00
Trial register
DUTCH Weight Control in Atrial Fibrillation StudyNot stated4--
2024-519533-38-00
Trial register
A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabetes.Not stated1--
NCT05071898
Trial register
Pharmacogenetics of Response to GLP1R Agonistscurrently recruiting participants-2021-10-08-
NCT05173714
Trial register
Sit Less, Interact and Move More (SLIMM) 2 Studycurrently recruiting participants-2021-12-30-
NCT06072963
Trial register
COMMETS- Combination MCI Metabolic Syndromecurrently recruiting participants-2023-10-10-
NCT07727473
Trial register
Preoperative Semaglutide Prior to Radical Prostatectomynot yet recruiting participants-2026-07-27-
NCT07728383
Trial register
A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesitycurrently recruiting participants-2026-07-27-
NCT07728812
Trial register
Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapynot yet recruiting participantsNA2026-07-10-
2023-508055-40-00
Trial register
Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c. 2.4 mg Once-weeklyNot stated4--
NCT07702461
Trial register
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonistscurrently recruiting participants-2026-07-14-
NCT07621640
Trial register
Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)not yet recruiting participants-2026-06-02-
NCT07720414
Trial register
Effects of GLP-1 RAs on Human Lactation Outcomescurrently recruiting participants-2026-07-17-
NCT07720466
Trial register
Salivary Function and Dental Changes During GLP-1 Therapynot yet recruiting participants-2026-07-14-
2024-513958-29-00
Trial register
Semaglutide for people with obesity and resistant hypertension (SUPPORT): a pilot, randomized, parallel-group, integrated, multicentre clinical trial.Not stated3--
NCT05503927
Trial register
A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancyenrolling by invitation only-2022-08-10-
NCT06497595
Trial register
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutidecurrently recruiting participants-2024-07-12-
NCT06967389
Trial register
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesitycurrently recruiting participants-2025-02-25-
NCT06975111
Trial register
Focusing on the Menopausal Transition to Improve Mid-Life Women's Healthcurrently recruiting participants-2025-05-16-
NCT07225816
Trial register
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutidecurrently recruiting participants-2025-11-10-
NCT07057310
Trial register
Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Womenenrolling by invitation only42025-07-09-
NCT07711548
Trial register
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?not yet recruiting participants-2026-07-14-
NCT07713992
Trial register
Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semagnot yet recruiting participants-2026-07-20-
2023-507449-27-01
Trial register
A biomarker-targeted clinical trial to optimize treatment for patients with chronic kidney diseaseNot stated4--
NCT06005012
Trial register
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMrunning, but no longer enrolling-2023-08-22-
NCT07272837
Trial register
Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Masscurrently recruiting participants-2025-12-09-
2023-509662-38-00
Trial register
Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) once weekly versus placebo in participants with type 2 diabetes and painful diabNot stated2--
NCT06814938
Trial register
A Study of a Novel Precision Medicine Approach For Obesityrunning, but no longer enrolling-2025-02-07-
NCT06982859
Trial register
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitusrunning, but no longer enrolling12025-05-21-
NCT07539415
Trial register
A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteerscurrently recruiting participants-2026-02-09-
NCT06575738
Trial register
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescentscurrently recruiting participants12024-08-28-
NCT07701005
Trial register
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesitycompleted-2026-07-14-
NCT07115069
Trial register
Comparison of Body Composition Changes With Weight Loss Interventionsrunning, but no longer enrolling-2025-07-25-
NCT07297238
Trial register
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.completed-2025-09-19-
NCT07091500
Trial register
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesitycurrently recruiting participants-2025-07-29-
NCT07653412
Trial register
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.currently recruiting participants-2026-06-17-
NCT07695454
Trial register
Imaging in Semaglutide Studynot yet recruiting participants-2026-07-10-
NCT07357740
Trial register
A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabeteswithdrawn before enrolling anyone-2026-01-21-
NCT07357766
Trial register
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weightwithdrawn before enrolling anyone-2026-01-21-
NCT07417618
Trial register
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)completed-2026-02-18-
NCT07619495
Trial register
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Riskcompleted-2026-06-02-
NCT07619508
Trial register
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.completed-2026-06-02-
2023-506929-11-00
Trial register
Efficacy and safety of cagrilintide s.c. in combination with semaglutide s.c. (CagriSema s.c.) once-weekly in participants with overweight or obesityNot stated3--
NCT04639414
Trial register
Combined Active Treatment in Type 2 Diabetes With NASHcompleted-2020-11-20-
NCT05574439
Trial register
Young Adults With Early-onset Obesity Treated With Semaglutidecompleted-2022-10-10-
NCT05616013
Trial register
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obesecompleted-2022-11-14Posted
NCT06003153
Trial register
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHcurrently recruiting participants-2023-08-21-
NCT06065540
Trial register
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Tcompleted-2023-10-04-
2024-520328-27-00
Trial register
J1R-MC-GZFD: A Parallel-Group Treatment, Phase 2, Double-Blind study of Once-Weekly Subcutaneous LY3457263 Compared to Placebo in Participants with Type 2 DiabeNot stated2--
NCT04777396
Trial register
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)completed-2021-03-02-
NCT04873245
Trial register
Lifestyle Counseling and Medication for Adolescent Weight Managementcompleted-2021-05-05-
NCT06640972
Trial register
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonistscompleted22024-10-08Posted
NCT07021937
Trial register
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesitynot yet recruiting participants-2025-06-15-
NCT07444073
Trial register
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clocknot yet recruiting participants-2026-02-12-
NCT07677865
Trial register
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulationcompleted-2026-06-24-
2024-510846-15-00
Trial register
Efficacy, safety, and pharmacokinetics of NNC0519-0130 once weekly s.c. versus semaglutide 1.0 mg and placebo in people with chronic kidney disease, with or witNot stated2--
NCT07430059
Trial register
Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implantnot yet recruiting participants-2026-02-24-
NCT06396416
Trial register
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2currently recruiting participants-2024-05-02-
2024-511114-20-00
Trial register
SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity secondary to craniopharyNot stated3--
NCT04777409
Trial register
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)completed-2021-03-02-
NCT07017270
Trial register
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysiscurrently recruiting participants-2025-06-12-
NCT07509112
Trial register
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Studynot yet recruiting participants-2026-04-03-
NCT07592546
Trial register
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Lossnot yet recruiting participants-2026-05-18-
NCT07597018
Trial register
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesitycurrently recruiting participants-2026-05-19-
NCT07505303
Trial register
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trialrunning, but no longer enrolling-2026-04-01-
NCT07668765
Trial register
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesitynot yet recruiting participants-2026-06-04-
NCT06380426
Trial register
A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesitycurrently recruiting participants-2024-04-23-
NCT05441267
Trial register
A Study of Cardiovascular Events iN Diabetes Plusrunning, but no longer enrolling-2022-07-01-
NCT06423599
Trial register
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failurecurrently recruiting participants-2024-05-21-
2025-523374-17-03
Trial register
Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the treatments with GLP-1Not stated4--
2024-520322-11-00
Trial register
A Randomized, Double-Blind, Placebo- and Open-Label Active Comparator- Controlled, Parallel-Group, Multi-Center Phase II Study to Evaluate the Efficacy, Safety,Not stated2--
NCT07502508
Trial register
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapycurrently recruiting participants-2026-03-26-
2025-522326-13-00
Trial register
Obesity and Semaglutide in Type 1 Diabetes Therapy (OBES1TY): A Multicentre, Randomised, Double-Blinded, Placebo-Controlled, Investigator-Initiated TrialNot stated3--
NCT05259033
Trial register
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in Peoplecompleted-2022-02-28Posted
NCT04572165
Trial register
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Ncompleted-2020-10-01-
NCT06184568
Trial register
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesitycompleted-2023-12-28-
NCT07642635
Trial register
Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophynot yet recruiting participants-2026-06-11-
NCT07282769
Trial register
Semaglutide (Wegovy) Treatment for Trichotillomanianot yet recruiting participants-2025-12-15-
NCT07462663
Trial register
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancernot yet recruiting participants-2025-11-23-
NCT07640139
Trial register
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomesenrolling by invitation only-2026-06-03-
NCT05622045
Trial register
Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Projectrunning, but no longer enrolling-2022-11-18-
NCT07107334
Trial register
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients Witcurrently recruiting participants22025-08-06-
NCT07633639
Trial register
GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesitycurrently recruiting participantsNA2026-06-08-
NCT04560998
Trial register
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetescompleted-2020-09-23Posted
NCT05356104
Trial register
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)currently recruiting participants-2022-04-08-
NCT06269107
Trial register
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People Wicompleted-2024-02-21-
NCT07628985
Trial register
BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetesnot yet recruiting participants-2026-06-05-
NCT05424003
Trial register
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplantcurrently recruiting participants-2022-06-21-
NCT06584916
Trial register
A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAcompleted32024-09-03-
NCT05813912
Trial register
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Typecompleted-2023-04-14Posted
NCT07204249
Trial register
Glutide for Ending Methamphetaminecurrently recruiting participants-2025-10-02-
NCT07622810
Trial register
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesitynot yet recruiting participants-2026-06-03-
NCT05822609
Trial register
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetescurrently recruiting participants-2023-04-21-
NCT06571383
Trial register
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Lossrunning, but no longer enrolling-2024-08-26-
NCT07605572
Trial register
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesitycurrently recruiting participants-2026-05-11-
NCT07621419
Trial register
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Reacurrently recruiting participants-2026-06-02-
NCT07617155
Trial register
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitisnot yet recruiting participants-2026-06-01-
NCT03899402
Trial register
Triple Therapy in T1DMrunning, but no longer enrolling-2019-04-02-
NCT07610174
Trial register
Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valvescompleted-2026-05-27-
NCT07613437
Trial register
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trialnot yet recruiting participants-2026-05-29-
NCT07614412
Trial register
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.not yet recruiting participants-2026-05-29-
NCT05333003
Trial register
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesityrunning, but no longer enrolling-2022-04-18-
NCT07221214
Trial register
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIVcurrently recruiting participants-2025-10-27-
2025-524612-11-00
Trial register
Effect of an adjunctive intervention on the tolerability of semaglutide in overweight adults without diabetes: a prospective, randomised, double-blind, single-cNot stated4--
NCT07456774
Trial register
A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patienrolling by invitation only-2026-03-06-
NCT07599046
Trial register
Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetesnot yet recruiting participants-2026-05-20-
2025-524738-24-00
Trial register
Healing Diabetic Foot Ulcers with SemaglutideNot stated4--
NCT04469855
Trial register
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®completed-2020-07-14-
NCT06289504
Trial register
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weightcompleted-2024-03-04-
NCT07317115
Trial register
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetescurrently recruiting participants-2026-01-05-
NCT06041217
Trial register
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Rangecompleted-2023-09-18Posted
NCT06790160
Trial register
Study of Patients Being Treated With Anti-obesity Medicationcurrently recruiting participants-2025-01-17-
NCT06827002
Trial register
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adultsrunning, but no longer enrolling-2025-02-14-
NCT06980623
Trial register
Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fractionrunning, but no longer enrolling-2025-05-20-
NCT07457424
Trial register
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)running, but no longer enrolling-2026-03-09-
NCT07588984
Trial register
GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Studynot yet recruiting participants-2026-05-15-
NCT07589322
Trial register
Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTscurrently recruiting participantsNA2026-05-15-
NCT07523633
Trial register
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disordercurrently recruiting participants-2026-04-13-
NCT07586150
Trial register
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)not yet recruiting participants-2026-05-14-
NCT06745284
Trial register
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesityrunning, but no longer enrolling-2024-12-20-
NCT06884293
Trial register
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)running, but no longer enrolling-2025-03-19-
NCT07581145
Trial register
Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patientscurrently recruiting participants-2026-05-12-
NCT05514535
Trial register
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People Witcompleted-2022-08-24Posted
NCT05586802
Trial register
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndromecurrently recruiting participants-2022-10-19-
NCT07187830
Trial register
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKDcurrently recruiting participants-2025-09-23-
NCT07547878
Trial register
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)not yet recruiting participants-2026-04-23-
NCT05035095
Trial register
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)completed-2021-09-05Posted
NCT07527195
Trial register
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)currently recruiting participants-2026-04-14-
2023-506109-20-00
Trial register
An interventional, multi-center, randomized, double blinded, placebo controlled study to investigate semaglutide add-on treatment for metabolic control in antipNot stated3--
NCT07570810
Trial register
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMnot yet recruiting participants-2026-05-06-
2024-512144-39-00
Trial register
Long-term efficacy and safety of cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (CagriSema 2.4 mg/2.4 mg) once weekly versus placebo in paNot stated3--
NCT05689372
Trial register
Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Renrolling by invitation only-2023-01-19-
NCT06388187
Trial register
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weightcompleted-2024-04-29-
NCT07041983
Trial register
24-h Energy Expenditure and Anti-obesity Medicationenrolling by invitation only-2025-05-28-
NCT04019197
Trial register
Effects of Semaglutide in HIV-Associated Lipohypertrophyrunning, but no longer enrolling-2019-07-15Posted
NCT05938712
Trial register
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplancurrently recruiting participants-2023-07-10-
NCT06613854
Trial register
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetescurrently recruiting participants-2024-09-26-
NCT07065383
Trial register
Rebalancing the Fat Content of the Heart and Musclescurrently recruiting participants-2025-07-15-
NCT07558863
Trial register
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetescurrently recruiting participants-2026-04-14-
NCT04174755
Trial register
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIVcurrently recruiting participants-2019-11-22-
NCT06263595
Trial register
Semaglutide and Preoperative Residual Gastric Volumescompleted-2024-02-16-
NCT06754163
Trial register
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patientsrunning, but no longer enrolling-2024-12-31-
NCT07229170
Trial register
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patientscurrently recruiting participants-2025-11-13-
NCT07487103
Trial register
Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetesnot yet recruiting participants-2026-03-17-
NCT07554417
Trial register
Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercisnot yet recruiting participants-2026-04-28-
2024-516542-19-00
Trial register
Searching simple biomarkers to phenotype type 2 diabetic patients and personalize their treatmentNot stated4--
NCT05649137
Trial register
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weightcompleted-2022-12-13Posted
NCT07081178
Trial register
A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practerminated before completion-2025-07-23-
2025-522486-29-01
Trial register
Impact of Oral Semaglutide on Platelet Reactivity in Patients with Diabetes Mellitus or Overweight with High Risk or established Cardiovascular Disease: the SEMNot stated3--
NCT05646706
Trial register
A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)completed-2022-12-12Posted
NCT07336862
Trial register
Bariatric Surgery Combined With GLP-1 Receptor Agonists Studycurrently recruiting participants-2025-09-29-
NCT06283667
Trial register
Special Use - Results Surveillance on Long-term Use With Wegovy®running, but no longer enrolling-2024-02-28-
NCT07539584
Trial register
Adiponectin in Patients With Metabolic Disorderscompleted-2026-04-13-
2025-524177-16-00
Trial register
An open-label, single-center, non-controlled pilot clinical trial to assess the efficacy of weekly semaglutide in combination with regular counselling sessions Not stated2--
NCT05746039
Trial register
Feasibility of Semaglutide in Advanced Lung Diseasecurrently recruiting participants-2023-02-27-
NCT06333080
Trial register
The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metforminterminated before completion-2024-03-27-
NCT06885736
Trial register
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapycurrently recruiting participantsNA2025-03-20-
NCT07281196
Trial register
Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apneacompleted-2025-12-15-
NCT07446439
Trial register
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Usecurrently recruiting participants-2026-02-10-
NCT06619015
Trial register
Tailoring Obesity Treatment Trialwithdrawn before enrolling anyone-2024-10-01-
NCT06903923
Trial register
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapycurrently recruiting participants-2025-04-01-
NCT07027969
Trial register
Metabolic Surgery for Atrial Fibrillation Eliminationnot yet recruiting participants42025-06-11-
2024-518086-99-00
Trial register
Young adults with early-onset obesity treated with semaglutide -The RESETTLE study - a randomized double blind placebo-controlled clinical trialNot stated4--
NCT05067621
Trial register
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Diseaserunning, but no longer enrolling-2021-10-05-
NCT06467604
Trial register
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Usersrunning, but no longer enrolling-2024-06-11-
NCT05390892
Trial register
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetescurrently recruiting participants-2022-05-19-
NCT06605703
Trial register
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatcompleted42024-09-20-
NCT06706284
Trial register
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetescurrently recruiting participants-2024-11-26-
NCT06751589
Trial register
A Study of a Weight Loss Intervention in People With Endometrial Cancercurrently recruiting participantsEARLY_12024-12-30-
NCT07073417
Trial register
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)running, but no longer enrolling-2025-07-18-
NCT05144984
Trial register
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetescompleted-2021-12-06Posted
NCT05195944
Trial register
Semaglutide vs Sitagliptinenrolling by invitation only-2022-01-19-
NCT06604624
Trial register
Semaglutide in Treatment of Obesitycompleted-2024-09-19-
NCT06830343
Trial register
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesitycurrently recruiting participants-2025-02-11-
NCT07513168
Trial register
Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adultscurrently recruiting participants-2026-04-06-
NCT07272343
Trial register
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetescurrently recruiting participants-2025-12-09-
2025-524163-21-00
Trial register
A randomized, double-blind, placebo-controlled trial of semaglutide for reducing cannabis use in adults with cannabis use disorderNot stated2--
2025-524819-37-00
Trial register
TheRapeutic StrAtegies for Obstructive SleeP Apnea in Older Adults with OverweigHt or Obesity: A RandomizEd Clinical TriaL (RAPHAEL study)Not stated4--
NCT06118203
Trial register
Semaglutide Use in Acute Pulmonary Embolismcompleted-2023-11-07-
NCT07361874
Trial register
IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretioncurrently recruiting participants-2026-01-23-
2022-500311-39-00
Trial register
Prevention of postoperative endoscopic recurrence with endoscopy-driven versus systematic biological therapy: a randomized, multicentre, parallel group pragmatiNot stated4--
NCT07040592
Trial register
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutidecurrently recruiting participants-2025-06-27-
NCT05925959
Trial register
Preoperative Weight Loss for Open Abdominal Wall Reconstructioncurrently recruiting participants-2023-06-14-
NCT06222437
Trial register
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategywithdrawn before enrolling anyone-2024-01-24-
NCT07216651
Trial register
WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adultscompleted-2025-10-14-
NCT07227948
Trial register
Repurposing Semaglutide for the Treatment of Cocaine Use Disordercurrently recruiting participants-2025-11-13-
NCT07483801
Trial register
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studiesnot yet recruiting participants42026-03-19-
NCT05119179
Trial register
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetescurrently recruiting participants-2021-11-15-
NCT06989177
Trial register
Probiotic Intervention on Body Weightcurrently recruiting participants-2025-05-25-
NCT06989203
Trial register
Protein Supplementation Intervention on Body Weightcurrently recruiting participants-2025-05-25-
NCT07207148
Trial register
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonistscurrently recruiting participants-2025-09-17-
NCT07195994
Trial register
A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediacurrently recruiting participants-2025-09-29-
NCT06409130
Trial register
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Diseasecompleted-2024-05-10-
NCT07400107
Trial register
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Losenot yet recruiting participants-2026-02-10-
NCT07465965
Trial register
A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adultscurrently recruiting participants-2026-03-12-
NCT06717698
Trial register
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Diseasecurrently recruiting participants-2024-12-05-
NCT07213466
Trial register
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disordercurrently recruiting participants-2025-10-09-
2025-522920-28-00
Trial register
Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle healthNot stated1--
2023-509273-24-00
Trial register
Efficacy and safety of cagrilintide s.c. in combination with semaglutide s.c. (CagriSema s.c. 1.0 mg/1.0 mg and 1.7 mg/1.7 mg) once-weekly in participants with Not stated3--
NCT05819138
Trial register
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomescurrently recruiting participants-2023-04-19-
NCT06027567
Trial register
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dicompleted-2023-09-07-
NCT06403761
Trial register
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetescompleted-2024-05-08-
NCT07285902
Trial register
A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesityrunning, but no longer enrolling-2025-12-16-
NCT05564117
Trial register
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Rangecompleted-2022-10-03Posted
NCT07172867
Trial register
A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DMwithdrawn before enrolling anyone-2025-09-15-
NCT07430332
Trial register
GLP-1 RA for Stage 1 Type 1 Diabetesnot yet recruiting participants-2026-02-24-
NCT07424430
Trial register
Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomesnot yet recruiting participants-2026-02-20-
NCT07280403
Trial register
Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Losscompleted-2025-12-12-
NCT07325500
Trial register
Incretin Microdosing for Cardiometabolic Health in People With HIVcurrently recruiting participants-2026-01-08-
NCT07101939
Trial register
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)currently recruiting participants-2025-08-03-
NCT07411378
Trial register
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.not yet recruiting participants-2026-02-13-
NCT04972721
Trial register
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trialcompleted-2021-07-22-
NCT06478550
Trial register
A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatmentcompleted-2024-06-27-
NCT06608433
Trial register
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Functioncompleted-2024-09-23-
NCT07294950
Trial register
Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Terminationcurrently recruiting participants-2025-12-19-
NCT07389941
Trial register
Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillationnot yet recruiting participants-2026-02-05-
NCT07401992
Trial register
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasiscurrently recruiting participants-2026-02-11-
NCT04779697
Trial register
GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weightcompleted-2021-03-03Posted
NCT04865770
Trial register
A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trcompleted-2021-04-29Posted
2023-506919-18-00
Trial register
A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (Not stated3--
NCT06131437
Trial register
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weightcompleted32023-11-14-
NCT07136714
Trial register
Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesitycurrently recruiting participants-2025-08-22-
NCT07392151
Trial register
Reversal to Normoglycemia by Treating Prediabetesnot yet recruiting participants-2026-01-23-
2023-506918-45-00
Trial register
A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (Not stated3--
NCT07391267
Trial register
Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.not yet recruiting participants-2026-02-05-
NCT03498001
Trial register
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imagingcompleted-2018-03-30-
NCT07382388
Trial register
A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasisnot yet recruiting participants-2026-01-20-
2022-502484-38-00
Trial register
A 40-week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL in participants with type 2 diabetes inadequateNot stated3--
2023-509483-20-00
Trial register
Investigating how CagriSema, semaglutide and cagrilintide regulate insulin effects in the body of people with type 2 diabetes.Not stated1--
NCT06914102
Trial register
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Datacompleted-2025-04-06-
NCT06914141
Trial register
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fractioncompleted-2025-04-06-
NCT04251156
Trial register
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.completed-2020-01-31Posted
NCT05040971
Trial register
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetescompleted-2021-09-10Posted
2022-502677-42-00
Trial register
Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) s.c. in doses 2.4 mg/2.4 mg and 1.0 mg/1.0 mg once weekly versus placebo in partNot stated3--
2022-502678-18-00
Trial register
Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) s.c. in doses 2.4/2.4 mg and 1.0/1.0 mg once weekly versus semaglutide 2.4 mg anNot stated3--
2025-523977-40-00
Trial register
Changes in Coronary Plaque Composition By Semaglutide Use in Diabetic Patients With Acute Coronary Syndrome: A Randomized Optical Coherence Tomography Trial - ANot stated4--
NCT05394519
Trial register
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weightcompleted-2022-05-27-
NCT07374328
Trial register
Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellituscurrently recruiting participants-2026-01-28-
NCT07141914
Trial register
A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real Worldcompleted-2025-08-26-
2022-502679-43-00
Trial register
Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) s.c. in doses 2.4 mg/2.4 mg and 1.0 mg/1.0 mg once weekly versus placebo in partNot stated3--
NCT05813925
Trial register
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weightcompleted-2023-04-14-
NCT05890976
Trial register
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)completed-2023-06-06-
NCT06132477
Trial register
Impact GLP-1 Agonists Following Bariatriccurrently recruiting participants-2023-11-02-
NCT06390501
Trial register
The Effect of Weekly Semaglutide Treatment on Energy Expenditurecompleted-2024-04-30-
NCT05788965
Trial register
Semaglutide in CFRDcompleted-2023-03-29Posted
NCT07242534
Trial register
Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.currently recruiting participants-2025-11-21-
NCT06780449
Trial register
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesityrunning, but no longer enrolling-2025-01-17-
NCT06500143
Trial register
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgerycompleted-2024-07-15-
NCT05579249
Trial register
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in Americacompleted-2022-10-13Posted
NCT05872022
Trial register
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancyenrolling by invitation only-2023-04-26-
NCT06577090
Trial register
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placeborunning, but no longer enrolling-2024-08-29-
NCT06852391
Trial register
JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesitycurrently recruiting participants-2025-02-28-
2023-505857-42-00
Trial register
Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema 2.4 mg/2.4 mg) once weekly versus semaglutide 2.4 mg, cagrilintide 2.4 mg and plaNot stated2--
NCT06042153
Trial register
DIALYSIS-TIR Studyrunning, but no longer enrolling-2023-09-18-
NCT06579105
Trial register
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.completed-2024-08-30-
NCT05829460
Trial register
Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasiawithdrawn before enrolling anyone-2023-04-25-
NCT05877547
Trial register
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)completed-2023-05-26-
NCT06648031
Trial register
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- completed12024-10-18-
NCT05996848
Trial register
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weightcompleted-2023-08-18-
NCT04969939
Trial register
A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesitycompleted-2021-07-21Posted
NCT06207877
Trial register
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weightcompleted-2024-01-17-
NCT06267092
Trial register
A Study of How CagriSema Works on Appetite in People With Excess Body Weightcompleted-2024-02-20-
NCT07302802
Trial register
Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practicecurrently recruiting participants-2025-12-24-
NCT07325435
Trial register
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonistsrunning, but no longer enrolling-2025-12-18-
NCT07323134
Trial register
The Effect of Semaglutide on the Intestinal Flora in Obesitynot yet recruiting participants-2026-01-07-
NCT07319975
Trial register
Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesitynot yet recruiting participantsNA2026-01-06-
NCT07295223
Trial register
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)currently recruiting participants-2025-12-19-
NCT07297589
Trial register
Epicardial Cardiac Fat-CT (EPIC-CT)currently recruiting participants-2025-12-22-
NCT07314684
Trial register
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DMcurrently recruiting participants-2026-01-02-
NCT04998136
Trial register
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesitycompleted-2021-08-10Posted
NCT05443191
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practicecompleted-2022-07-05-
NCT06507475
Trial register
Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetescompleted-2024-07-18-
NCT07309094
Trial register
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKDcurrently recruiting participants-2025-12-30-
NCT05702931
Trial register
Semaglutide Treatment for Hyperglycaemia After Renal Transplantationcurrently recruiting participants-2023-01-27-
NCT05892432
Trial register
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)completed-2023-06-07-
NCT06801015
Trial register
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Frunning, but no longer enrolling42025-01-30-
2024-511734-13-04
Trial register
Is the glucagon-like peptide-1 receptor agonist semaglutide able to alleviate mood in patients with major depressive disorder and overweight or obesity? Sema-MoNot stated3--
2025-523374-17-01
Trial register
Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the treatments with GLP-1Not stated4--
NCT04982575
Trial register
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetescompleted-2021-07-29Posted
NCT07058155
Trial register
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Diseasecurrently recruiting participants42025-06-27-
NCT06954090
Trial register
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Studyenrolling by invitation only-2025-05-01-
NCT06983171
Trial register
Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practicerunning, but no longer enrolling-2025-05-21-
NCT06468748
Trial register
The Effects of Semaglutide on Body Composition and Performance in Military Personnelwithdrawn before enrolling anyone-2024-06-21-
NCT07293325
Trial register
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesitycurrently recruiting participantsNA2025-12-19-
2023-508170-28-00
Trial register
Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver Not stated2--
NCT06338553
Trial register
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumabcurrently recruiting participants-2024-03-29-
NCT06972992
Trial register
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutidecompleted-2025-05-15-
2025-524182-25-00
Trial register
Waiting on Atrial fibrillation Intervention Therapy (WAIT) StudyNot stated4--
NCT05891587
Trial register
Semaglutide Therapy for Alcohol Reduction - Tulsacompleted-2023-06-07-
NCT04940078
Trial register
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesitycompleted-2021-06-25-
NCT05478252
Trial register
A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetescompleted-2022-07-28Posted
NCT05486065
Trial register
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweightcompleted-2022-08-03Posted
NCT03914326
Trial register
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetescompleted-2019-04-16Posted
NCT04102189
Trial register
A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesitycompleted-2019-09-25Posted
NCT07276763
Trial register
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retentionnot yet recruiting participants-2025-11-29-
2022-502647-35-00
Trial register
A Phase 2b Randomized, Double-Blind Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults with PrecirrNot stated2--
NCT06069622
Trial register
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatmentcurrently recruiting participants-2023-10-06-
2025-521748-39-00
Trial register
SGLT-2i, Heart, Improvement of Cardiovascular Autonomic NeuropathyNot stated4--
NCT04707469
Trial register
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetescompleted-2021-01-13Posted
NCT07096739
Trial register
Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1completed-2025-07-24-
NCT04559815
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practicecompleted-2020-09-23-
NCT04788511
Trial register
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesitycompleted-2021-03-09Posted
NCT06533527
Trial register
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopycompleted42024-06-27Posted
NCT05352815
Trial register
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in Peoplecompleted-2022-04-29Posted
NCT05013229
Trial register
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in Peoplecompleted-2021-08-19-
NCT05784402
Trial register
A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participantscompleted-2023-03-24-
NCT07251556
Trial register
GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritisnot yet recruiting participants-2025-11-26-
NCT07254572
Trial register
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetescurrently recruiting participants-2025-11-28-
NCT04916470
Trial register
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetescompleted-2021-06-07-
NCT04971785
Trial register
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)completed-2021-07-21Posted
NCT05822830
Trial register
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbiditiescompleted32023-04-21Posted
NCT06410352
Trial register
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndromecurrently recruiting participants-2024-05-13-
2024-513416-98-00
Trial register
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes: A Randomized Open Intervention Study That Compares Empagliflozin, Pioglitazone and Semaglutide (DiNot stated2--
2024-515417-17-00
Trial register
A study in people with obesity to test the effects of different doses of BI 456906 compared with semaglutide on glucagon receptor activity in the liverNot stated1--
2025-520802-37-00
Trial register
Impact of GLP1-RAs on inflammation and endothelial biomarkerS in Type 2 diABetes meLlitus patiEnts: STABLE-GLP1 trial.Not stated4--
NCT03919929
Trial register
Treating PCOS With Semaglutide vs Active Lifestyle Interventioncompleted-2019-04-18Posted
NCT06778967
Trial register
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitusrunning, but no longer enrolling-2025-01-16-
NCT07150975
Trial register
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjectscurrently recruiting participants-2025-09-02-
NCT07154238
Trial register
Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-countenrolling by invitation only-2025-09-04-
2025-522970-35-00
Trial register
REVERsal to normoglycemia by Treating PREDIABETES: the REVERT-PREDIABETES trialNot stated3--
NCT06420739
Trial register
The Semaglutide Studyrunning, but no longer enrolling-2024-05-20-
NCT07239570
Trial register
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Diseasecurrently recruiting participants-2025-11-20-
2022-502082-22-00
Trial register
Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes: a double blind RCTNot stated3--
NCT05016882
Trial register
Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)completed-2021-08-23-
NCT05064735
Trial register
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritiscompleted-2021-10-01Posted
NCT06499857
Trial register
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillationcurrently recruiting participants-2024-07-15-
2023-505959-45-00
Trial register
The effect of oral Semaglutide on bone turnover in patients with T2D: a randomized placebo-controlled clinical trial (SOBER II)Not stated2--
NCT06446531
Trial register
Prevention of Progression of Prediabetes, Obesity and CV Riskcurrently recruiting participants-2024-05-31-
NCT06804603
Trial register
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Usecompleted-2025-01-09-
NCT05768945
Trial register
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitorscompleted-2023-03-15Posted
NCT07223242
Trial register
Tailored Exercise Training Study Among Adults With HFpEFcurrently recruiting participants2/32025-10-06-
NCT07064486
Trial register
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesiacurrently recruiting participants-2025-07-14-
2023-506923-27-00
Trial register
PIONEER TEENS Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with tyNot stated3--
2025-522525-34-00
Trial register
Effect of Semaglutide on embryo quality in overweight and obese patients undergoing In Vitro Fertilization. A Randomized Controlled TrialNot stated4--
NCT06642584
Trial register
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IVcompleted-2024-10-15-
NCT06659744
Trial register
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claimscompleted-2024-10-26-
NCT07096063
Trial register
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Riskcompleted-2025-07-31-
NCT05443568
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practicecompleted-2022-07-05-
NCT04466345
Trial register
Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disordercompleted-2020-07-10-
NCT05755360
Trial register
DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatmecompleted-2023-03-06-
NCT07200622
Trial register
Oral Semaglutide in Patients With Alzheimer's Diseasenot yet recruiting participants-2025-10-01-
2023-504913-65-01
Trial register
The SEMAFOOT2 Pilot. Effect of semaglutide on healing of foot ulcers in type 2 diabetes patients. A Pilot study.Not stated2--
NCT06639464
Trial register
Semaglutide for Helping Opioid Recoverycurrently recruiting participants-2024-10-15-
NCT04537637
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practicecompleted-2020-09-03-
NCT04601740
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practicecompleted-2020-10-26-
NCT04601753
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practicecompleted-2020-10-26-
NCT04862923
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practicecompleted-2021-04-28-
NCT04878393
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practicecompleted-2021-05-07-
NCT05230589
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practicecompleted-2022-02-09-
NCT05230615
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practicecompleted-2022-02-09-
NCT05316662
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practicecompleted-2022-04-07-
NCT05443334
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practicecompleted-2022-07-05-
NCT05533632
Trial register
Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetescompleted-2022-09-09Posted
NCT05996874
Trial register
A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participantscompleted-2023-08-18-
NCT07190144
Trial register
Coronary Flow Reserve Changes After Semaglutide Treatmentcompleted-2025-09-24-
NCT05670379
Trial register
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implantcompleted-2023-01-04-
NCT07187856
Trial register
Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitusnot yet recruiting participants-2025-09-23-
NCT07188545
Trial register
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Rearunning, but no longer enrolling-2025-09-16-
2023-506931-13-00
Trial register
Efficacy and safety of cagrilintide s.c. in combination with semaglutide s.c. (CagriSema s.c.) once-weekly in participants with overweight or obesity and type 2Not stated3--
NCT06282458
Trial register
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmtcompleted-2024-02-28-
NCT07165158
Trial register
The Effect of Semaglutide on Bone Healthnot yet recruiting participants-2025-09-10-
NCT07179120
Trial register
Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Healthnot yet recruiting participants22025-09-17-
NCT07042672
Trial register
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesitycurrently recruiting participants-2025-04-03-
2025-522503-18-00
Trial register
Semaglutide and Finerenone for Kidney and Vascular Protection in CKDNot stated4--
NCT04126603
Trial register
Impact of Semaglutide on CD34+ EPC and Fat Derived MSCcompleted-2019-10-15Posted
NCT05756764
Trial register
Anti-obesity Pharmacotherapy and Inflammationrunning, but no longer enrolling-2023-03-06-
NCT07156331
Trial register
Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetesnot yet recruiting participants-2025-08-07-
NCT07156591
Trial register
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retentionnot yet recruiting participants-2025-09-05-
NCT06500429
Trial register
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonistcompleted-2024-07-15-
NCT05537233
Trial register
ADJUnct Semaglutide Treatment in Type 1 Diabetescompleted-2022-09-13Posted
NCT06292065
Trial register
Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapycompleted-2024-03-04-
NCT07152756
Trial register
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scoresnot yet recruiting participants-2025-09-03-
NCT05897398
Trial register
SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®completed-2023-05-31-
2023-508525-27-00
Trial register
A multiarm, randomized, open label Clinical study comparing AntiatheroSClerotic efficacy of selected Antidiabetic agents in patients with coronary artery diseasNot stated4--
NCT06986993
Trial register
Impact of Semaglutide on Tobacco Use and Related Health Behaviorscurrently recruiting participants-2025-05-23-
NCT07139548
Trial register
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetesnot yet recruiting participants-2025-08-24-
NCT05530577
Trial register
Effects of Semaglutide on Nicotine Intakecompleted-2022-09-07Posted
NCT07135245
Trial register
Improved Treatment and Monitoring of Alzheimer's Diseasenot yet recruiting participants-2025-08-22-
NCT06909006
Trial register
Semaglutide Treatment in Type 1 Diabetesnot yet recruiting participants-2025-04-03-
NCT05895643
Trial register
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?completed-2023-06-08-
NCT06118008
Trial register
A Study of HS-20094 in T2DM Participantscompleted-2023-05-25-
NCT06634927
Trial register
Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.completed-2024-10-10-
NCT07092605
Trial register
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measuresenrolling by invitation only-2024-12-18-
NCT07092618
Trial register
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessationcurrently recruiting participants-2024-12-18-
NCT07090343
Trial register
Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacementnot yet recruiting participants-2025-07-29-
NCT06739044
Trial register
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetescompleted-2024-12-18-
NCT07073053
Trial register
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanismsnot yet recruiting participants-2025-07-18-
NCT06097390
Trial register
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IIIcompleted-2023-10-24-
NCT07056803
Trial register
Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellituscompleted-2025-07-09-
NCT04451837
Trial register
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiologyrunning, but no longer enrolling-2020-06-30-
NCT06161844
Trial register
Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellituscompleted-2023-12-08-
NCT07043361
Trial register
Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levelscompleted-2025-06-29-
2023-503371-25-00
Trial register
Does the Glucagon-like Peptide 1 (GLP-1) receptor agonist semaglutide reduce alcohol intake in patients with Alcohol Use Disorder and comorbid obesity?Not stated2--
NCT07046273
Trial register
Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetesnot yet recruiting participants-2025-07-01-
NCT07035704
Trial register
Prevent and Reverse Obesity in Children, Adolescents and Young Adultsnot yet recruiting participants-2025-06-10-
NCT07036172
Trial register
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patientscurrently recruiting participants-2025-06-25-
NCT07030621
Trial register
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trialnot yet recruiting participants-2025-06-22-
2022-502139-20-00
Trial register
Semaglutide Treatment for Prevention of Toxicity in High-dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation - a randomized, double-blind,Not stated2--
NCT06060392
Trial register
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellituscurrently recruiting participants-2023-09-29-
NCT07018544
Trial register
A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Weenrolling by invitation only-2025-06-12-
NCT05303857
Trial register
Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetescompleted-2022-03-31-
NCT06363487
Trial register
Semaglutide and Cognition in Healthy Volunteerscompleted-2024-04-12-
2024-517120-19-02
Trial register
Glucagone Like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as treatment of Idiopathic Intracranial HypertensionNot stated4--
NCT06492330
Trial register
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DMcompleted-2024-07-09-
NCT06924697
Trial register
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patientsenrolling by invitation only-2025-04-11-
2023-504988-16-00
Trial register
The effect of semaglutide therapy on hepatic fat content and on the acute reponse of liver fat to high-fat load in obese MASLD patientsNot stated3--
NCT06659679
Trial register
Emulating the PIONEER6 Diabetes Trial Using Healthcare Claimscompleted-2024-10-26-
NCT06659718
Trial register
Emulation of the SOUL Diabetes Trial in Healthcare Claimscompleted-2024-10-26-
2022-502717-28-00
Trial register
A single arm study investigating the glycaemic control and safety of adding semaglutide to insulin icodec in participants with type 2 diabetes qualifying for trNot stated3--
NCT06987669
Trial register
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Usersnot yet recruiting participants-2025-05-08-
NCT06874751
Trial register
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real Worldcompleted-2025-03-13-
NCT06974825
Trial register
A Study of BGM0504 in Chinese Patients With Type 2 Diabetescompleted-2025-05-16-
NCT06937060
Trial register
Effect of Semaglutide in Patients With Psoriasis and Obesitycurrently recruiting participants-2025-04-20-
NCT05419726
Trial register
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.currently recruiting participants-2022-06-15-
2024-518040-21-00
Trial register
A Phase 1 Trial Assessing Pharmacokinetics and Safety of CAM2056 (Semaglutide Subcutaneous Depot)Not stated1--
NCT06959784
Trial register
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)enrolling by invitation only-2025-05-07-
NCT05786521
Trial register
Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adultscompleted-2023-03-27Posted
NCT04032197
Trial register
A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetescompleted-2019-07-25-
NCT06946628
Trial register
New Triple Therapy in Newly Diagnosed Type 2 Diabetesnot yet recruiting participants-2025-03-03-
NCT04889183
Trial register
SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetescompleted-2021-05-17-
NCT05302596
Trial register
Semaglutide Use in Elderly Obese Patientscompleted-2022-03-31Posted
NCT06351748
Trial register
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)completed-2024-04-08-
NCT05520775
Trial register
Semaglutide for Alcohol Use Disordercompleted-2022-08-30Posted
NCT06896981
Trial register
Semaglutide in Women With Polycystic Ovary Syndrome and Obesitycurrently recruiting participants-2025-03-26-
NCT06487832
Trial register
Effect of GLP1 Receptor Agonist on Brain Insulin Responsivenesscurrently recruiting participants-2024-06-27-
NCT06894784
Trial register
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type currently recruiting participants-2025-03-25-
NCT05340868
Trial register
Genetics of the Acute Response to Oral Semaglutidecurrently recruiting participants-2022-04-22-
NCT05435677
Trial register
A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Togethercompleted-2022-06-28-
NCT06734312
Trial register
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)currently recruiting participantsNA2024-12-10-
NCT03819153
Trial register
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Diseasecompleted-2019-01-28Posted
NCT04979130
Trial register
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)completed-2021-07-28-
NCT05078255
Trial register
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetescompleted-2021-10-14-
NCT04873050
Trial register
Treatment to Regress to Normoglycemia in Women with a Recent History of GDMcurrently recruiting participants-2021-05-05-
2024-510612-75-00
Trial register
Efficacy and safety of once-weekly semaglutide s.c. 2.0 mg as add-on to dose-reduced insulin glargine vs titrated insuline glargine in participants with type 2 Not stated3--
NCT04817644
Trial register
A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tabletscompleted-2021-03-26-
NCT05920889
Trial register
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapiescompleted-2023-06-27-
NCT06863363
Trial register
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adultsnot yet recruiting participants-2025-03-07-
2022-502164-20-01
Trial register
Semaglutide 2.4mg for low responders after bariatric surgeryNot stated4--
NCT06856928
Trial register
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.not yet recruiting participants-2025-02-13-
NCT05501483
Trial register
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetescurrently recruiting participants-2022-08-15-
NCT06400615
Trial register
Study That Tests AD109 in Patients Taking GLP-1 Drugscompleted22024-04-12-
NCT04538352
Trial register
Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2Dcompleted-2020-09-04Posted
2023-506825-13-00
Trial register
A randomised double-blind placebo-controlled clinical study investigating the effects of semaglutide s.c. once-weekly versus placebo on central and peripheral iNot stated3--
NCT05812183
Trial register
Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesitywithdrawn before enrolling anyone42023-03-31-
NCT06825793
Trial register
Semaglutide's Weight Loss Effects in Obesitynot yet recruiting participants-2025-02-13-
NCT06821919
Trial register
Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)currently recruiting participants-2025-01-26-
NCT06820047
Trial register
Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Studycompleted-2025-01-27-
NCT06363747
Trial register
The Medically Reproducing Bariatric Surgery (MRB) II Studyrunning, but no longer enrolling-2024-04-09-
NCT06716216
Trial register
A Study of BGM0504 in Participants with Type 2 Diabetescurrently recruiting participants-2024-12-04-
NCT05700877
Trial register
Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetescurrently recruiting participants-2023-01-05-
NCT06792422
Trial register
A Study Investigating Oral Semaglutide in People with Open-Angle Glaucomacurrently recruiting participants-2025-01-24-
NCT06788626
Trial register
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatmentnot yet recruiting participants-2025-01-23-
2023-506961-74-00
Trial register
Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-contrNot stated2--
NCT05205928
Trial register
Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Carecompleted-2022-01-25-
NCT05751226
Trial register
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglucompleted-2023-03-02-
2024-517463-23-00
Trial register
Weight management with orismilast alone or in combination with s.c. semaglutide (WELOSITI)Not stated2--
NCT04515849
Trial register
A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellituscompleted-2020-08-17Posted
NCT05671653
Trial register
A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, andterminated before completion-2023-01-05Posted
NCT06761703
Trial register
A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Losscompleted-2025-01-01-
NCT06082063
Trial register
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetescurrently recruiting participants-2023-10-13-
NCT06764056
Trial register
Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)not yet recruiting participants-2025-01-08-
NCT06387199
Trial register
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutidecurrently recruiting participants-2024-04-26-
NCT06234111
Trial register
Semaglutide and Physical Activity for Obesity and Multimorbidityrunning, but no longer enrolling-2024-01-31-
NCT05073835
Trial register
Semaglutide 2.4 mg in Patients With Poor Weight-lossrunning, but no longer enrolling-2021-10-12-
NCT06629688
Trial register
Semaglutide and Intestinal Iron Absorptioncompleted-2024-10-08-
2024-510802-10-00
Trial register
The impact of pramlintide on top of semaglutide in obese people with prediabetesNot stated2/3--
NCT06699329
Trial register
A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)completed-2024-11-21-
2024-518510-87-00
Trial register
Additive Benefits of Semaglutide for open-AngLe glaucoma - an Opportunity for Neuroprotection (ABSALON)Not stated4--
NCT06686134
Trial register
Comprehensive Clinical Evaluation Study of GLP-1RAcurrently recruiting participants-2024-11-01-
NCT03789578
Trial register
A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Togethercompleted-2018-12-28-
NCT06581120
Trial register
GLP_1 RA Ultrasound Studyenrolling by invitation only-2024-09-03-
2024-518746-24-00
Trial register
Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia trNot stated2--
NCT05087342
Trial register
Latino Semaglutide Studycompleted-2021-10-21-
NCT05689099
Trial register
A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dosecompleted-2023-01-18-
NCT06633783
Trial register
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®not yet recruiting participants-2024-10-09-
NCT06318442
Trial register
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetescurrently recruiting participants-2024-03-19-
NCT04017832
Trial register
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetescompleted-2019-07-12Posted
NCT04216589
Trial register
Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiocompleted-2020-01-02Posted
NCT06616961
Trial register
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitusnot yet recruiting participants-2024-09-27-
NCT04892199
Trial register
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?last verified some time ago; the register no longer confirms its status-2021-05-19-
NCT05577728
Trial register
Prediction of the SEPRA Diabetes Trial in Healthcare Claims Datacompleted-2022-10-13-
NCT05897372
Trial register
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Studyterminated before completion-2023-06-09-
NCT04109547
Trial register
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetescompleted-2019-09-30Posted
NCT04537624
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practicecompleted-2020-09-03-
NCT05227196
Trial register
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy Peoplecompleted-2022-02-07-
NCT05236517
Trial register
A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesitycompleted-2022-02-11-
NCT05502562
Trial register
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in Indiacompleted-2022-08-16-
NCT03574597
Trial register
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesitycompleted-2018-07-02Posted
2023-506434-69-00
Trial register
FINESSE; Optimization of albuminuria lowering therapies to individual patients with CKD using FINErenone and SEmaglutide (FINESSE-CKD)Not stated2--
NCT06557811
Trial register
Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarctionlast verified some time ago; the register no longer confirms its status-2024-08-16-
NCT06555146
Trial register
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathylast verified some time ago; the register no longer confirms its status-2024-08-15-
NCT05429593
Trial register
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tabletcompleted-2022-06-23-
NCT06541509
Trial register
Mechanisms of Semaglutide Therapy in Heart Failure Patientslast verified some time ago; the register no longer confirms its status-2024-08-07-
NCT04990024
Trial register
The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutidelast verified some time ago; the register no longer confirms its status-2021-08-04-
NCT05579977
Trial register
Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesityterminated before completion-2022-10-11Posted
NCT06449235
Trial register
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladeshlast verified some time ago; the register no longer confirms its status-2024-06-07-
NCT04016974
Trial register
A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinesecompleted-2019-07-12-
NCT06497049
Trial register
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.completed-2024-07-04-
NCT05193578
Trial register
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetescompleted-2022-01-18-
NCT06489457
Trial register
The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesitycompleted-2024-07-08-
NCT06475586
Trial register
Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellituscompleted-2024-06-26-
2024-510885-17-01
Trial register
Defining the Glucagon Unit: Investigating the Impact on Energy Expenditure and Glucose Level Deviation in healthy volunteersNot stated1--
NCT06461377
Trial register
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathycurrently recruiting participants-2024-06-17-
NCT06449625
Trial register
Semaglutide in Auto-HSCTnot yet recruiting participants-2024-06-10-
NCT05780905
Trial register
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetescurrently recruiting participants-2023-03-23-
NCT03987451
Trial register
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damagecompleted-2019-06-17Posted
NCT05129891
Trial register
A Research Study Looking at New Protein-based Tablets in Healthy Male Participantscompleted-2021-11-22-
NCT06426446
Trial register
Monitoring Patients With Severe Obesity Treated With Wegovy® Using Connected Device: Real-world Datalast verified some time ago; the register no longer confirms its status-2024-05-13-
NCT06422624
Trial register
A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjectslast verified some time ago; the register no longer confirms its status-2024-05-21-
NCT05646199
Trial register
Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)last verified some time ago; the register no longer confirms its status-2022-12-12-
NCT06361823
Trial register
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatmentlast verified some time ago; the register no longer confirms its status-2024-04-12-
NCT06354101
Trial register
The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Withoutwithdrawn before enrolling anyone-2024-04-09-
NCT06344247
Trial register
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Diseaselast verified some time ago; the register no longer confirms its status-2024-03-17-
NCT05813249
Trial register
Semaglutide in Nonalcoholic Fatty Liver Diseasecompleted-2023-04-14-
NCT06339086
Trial register
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2024-04-01-
NCT05702905
Trial register
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndromelast verified some time ago; the register no longer confirms its status-2023-01-27-
NCT06301191
Trial register
The Effect of Semaglutide on Cardiovascular Markers and Liver Functionlast verified some time ago; the register no longer confirms its status-2024-03-08-
NCT06298799
Trial register
GENETIC VARIABILITY TO GLP1 TREATMENTlast verified some time ago; the register no longer confirms its status-2024-03-01-
NCT06149260
Trial register
Subcutaneous Semaglutide in Systemic Sclerodermalast verified some time ago; the register no longer confirms its status-2023-11-28-
NCT06287307
Trial register
Semaglutide 2.4mg for Low Responders After Bariatric Surgerylast verified some time ago; the register no longer confirms its status-2024-03-01-
NCT05766709
Trial register
A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulationscompleted-2023-03-13-
NCT05136287
Trial register
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTcompleted-2021-11-29-
NCT05390307
Trial register
Obesity Treatment to Improve Diabetescompleted-2022-05-25-
NCT06083675
Trial register
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabeteswithdrawn before enrolling anyone-2023-10-16-
NCT06256549
Trial register
A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellituslast verified some time ago; the register no longer confirms its status-2024-02-13-
NCT06221696
Trial register
Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways)completed-2024-01-24-
NCT04741074
Trial register
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacyterminated before completion-2021-02-05Posted
NCT06243536
Trial register
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patientslast verified some time ago; the register no longer confirms its status-2024-02-06-
NCT06120556
Trial register
Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypescompleted-2023-11-07-
NCT05232708
Trial register
A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutidecompleted-2022-02-10-
NCT06215196
Trial register
Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesitycompleted-2024-01-22-
NCT05751720
Trial register
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analoguelast verified some time ago; the register no longer confirms its status1/22023-03-02-
NCT05716724
Trial register
O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emiratecompleted-2023-02-08-
NCT05816057
Trial register
A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellituscompleted-2023-04-18-
NCT06182618
Trial register
Retrospective Analysis for Patients With Metabolic Syndromelast verified some time ago; the register no longer confirms its status-2023-12-27-
NCT05498610
Trial register
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Mencompleted-2022-08-12-
2023-503949-65-00
Trial register
A research study comparing the effect of different dosing conditions on blood levels of semaglutide in a new tablet composition in healthy participantsNot stated1--
NCT06154486
Trial register
Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Studycompleted-2023-12-04-
NCT04944992
Trial register
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)completed-2021-06-30Posted
NCT04624672
Trial register
Treatment of GLP-1 for Diabetic Bariatric Patientsterminated before completion-2020-11-12Posted
NCT04259801
Trial register
First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People completed-2020-02-06-
NCT05153564
Trial register
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopausecompleted-2021-12-10-
NCT04885634
Trial register
Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patientswithdrawn before enrolling anyone-2021-05-13-
NCT04524832
Trial register
Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy Peoplecompleted-2020-08-24-
NCT03985384
Trial register
Semaglutide Treatment On Coronary Progressioncompleted-2019-06-13-
NCT06057077
Trial register
Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-boluslast verified some time ago; the register no longer confirms its status-2023-09-28-
NCT04263415
Trial register
The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesitycompleted-2020-02-10-
NCT05990374
Trial register
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Yearslast verified some time ago; the register no longer confirms its statusNA2023-08-14-
NCT05870462
Trial register
Semaglutide and Vascular Regenerationlast verified some time ago; the register no longer confirms its status-2023-05-23-
NCT05950516
Trial register
Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2023-07-18-
2023-504159-29-00
Trial register
Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantationNot stated2--
NCT03693430
Trial register
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesitycompleted-2018-10-03Posted
NCT05046873
Trial register
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy Peoplecompleted-2021-09-16-
NCT05161429
Trial register
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabeteslast verified some time ago; the register no longer confirms its status-2021-11-23-
2022-501072-25-02
Trial register
The safety and efficacy of acute subcutaneous administration of semaglutide in non-diabetic patients with acute ischemic stroke: a multicentre, phase 2, prospecNot stated2--
NCT01511393
Trial register
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)enrolling by invitation only-2011-11-30-
NCT04938388
Trial register
Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Careterminated before completion-2021-06-24-
NCT04074161
Trial register
Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesitycompleted-2019-08-29Posted
NCT04878406
Trial register
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Mencompleted-2021-05-07-
NCT05779644
Trial register
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellituslast verified some time ago; the register no longer confirms its status-2023-03-22-
NCT04513704
Trial register
A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Timescompleted-2020-08-14-
NCT05857085
Trial register
Novel Therapeutics and Endothelial Dysfunction in T1DM Patientscompleted-2023-05-12-
NCT04200625
Trial register
Semaglutide vs Dulaglutide on Epicardial Adipose Tissuecompleted-2019-12-16-
NCT05597202
Trial register
Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2022-10-27-
NCT05630586
Trial register
Acute Subcutaneous SemaglutidE in Acute Ischemic sTrokecurrently recruiting participants-2022-11-29-
2022-500007-52-00
Trial register
A study comparing exposure of semaglutide and dapagliflozin dosed orally as mono-components versus in a fixed-dose combinationNot stated1--
NCT04083820
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)completed-2019-09-10-
NCT04261933
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)completed-2020-02-10-
NCT03951753
Trial register
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)completed12019-05-15Posted
NCT03292315
Trial register
Once Weekly GLP-1 in Persons With Spinal Cord Injurycompleted-2017-09-25-
NCT04094415
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practicecompleted-2019-09-19-
NCT04865744
Trial register
The Effect of Semaglutide on Pituitary Functioncompleted-2021-04-29-
NCT05468632
Trial register
A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environmentcompleted-2022-07-21-
NCT03989232
Trial register
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetescompleted-2019-06-18Posted
2022-501106-35-00
Trial register
I8F-MC-GPHJ: A Phase 3b, Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Compared to Semaglutide 2.4 mg in Adults Who Have ObesitNot stated3--
NCT03929679
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)completed-2019-04-29-
NCT04153929
Trial register
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.completed-2019-11-06Posted
NCT05616052
Trial register
Comparison of Body Weight Change Through Different Smeglutide Administration Methodslast verified some time ago; the register no longer confirms its status-2022-11-15-
NCT03689374
Trial register
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetescompleted-2018-09-28Posted
NCT05444153
Trial register
Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesitywithdrawn before enrolling anyone-2022-07-05-
NCT04189848
Trial register
Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sccompleted-2019-12-06Posted
NCT05606471
Trial register
Glucagon-like Peptide-1 Agonism With Very Low Calorie Dietslast verified some time ago; the register no longer confirms its status-2022-11-04-
NCT05209165
Trial register
Semaglutide to Reduce Atrial Fibrillation Burdensuspended-2022-01-26-
NCT05322200
Trial register
The POST-ACS Studylast verified some time ago; the register no longer confirms its status-2022-02-11-
NCT05473286
Trial register
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practicewithdrawn before enrolling anyone-2022-07-25-
NCT05492305
Trial register
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Healthlast verified some time ago; the register no longer confirms its status-2022-08-08-
NCT04097600
Trial register
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tabletscompleted-2019-09-20-
NCT05249881
Trial register
"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."last verified some time ago; the register no longer confirms its status-2022-02-22-
NCT02607865
Trial register
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetescompleted-2015-11-18Posted
NCT02692716
Trial register
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetescompleted-2016-02-26Posted
NCT02849080
Trial register
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitcompleted-2016-07-29Posted
NCT02863328
Trial register
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellituscompleted-2016-08-11Posted
NCT02863419
Trial register
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellituscompleted-2016-08-11Posted
NCT02906930
Trial register
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Onlycompleted-2016-09-20Posted
NCT05442450
Trial register
Efficacy of Oral Semaglutide in Overweight or Obesitylast verified some time ago; the register no longer confirms its status-2022-07-05-
NCT05147896
Trial register
Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patientslast verified some time ago; the register no longer confirms its status-2021-12-07-
NCT04854083
Trial register
Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2021-04-22-
NCT03811574
Trial register
STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesitycompleted-2019-01-22Posted
NCT03987919
Trial register
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetescompleted32019-06-17Posted
NCT04615871
Trial register
Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19last verified some time ago; the register no longer confirms its status-2020-11-04-
NCT04287179
Trial register
SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabeteswithdrawn before enrolling anyone-2020-02-27-
NCT03548987
Trial register
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesitycompleted-2018-06-07Posted
NCT04228354
Trial register
A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutidecompleted-2020-01-14-
NCT03357380
Trial register
A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Livercompleted-2017-11-29-
NCT03548935
Trial register
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesitycompleted-2018-06-07Posted
NCT03600480
Trial register
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obesecompleted-2018-07-26-
NCT02970942
Trial register
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.completed-2016-11-22Posted
NCT03648281
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)completed-2018-08-27-
NCT03611582
Trial register
Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Programcompleted-2018-08-02Posted
NCT04187300
Trial register
A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesitycompleted-2019-12-05-
NCT04152915
Trial register
A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Penscompleted-2019-11-05-
NCT03552757
Trial register
Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesitycompleted-2018-06-12Posted
NCT05071417
Trial register
Effect Of Semaglutide In Coronary Atheroma Plaquelast verified some time ago; the register no longer confirms its status-2021-10-08-
NCT04067999
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practicecompleted-2019-08-28-
NCT03457012
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practicecompleted-2018-03-07-
NCT03631186
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)completed-2018-08-15-
NCT03987074
Trial register
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)completed-2019-06-14Posted
NCT03086330
Trial register
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellituscompleted-2017-03-22Posted
NCT03574584
Trial register
A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obesecompleted-2018-07-02-
NCT04702516
Trial register
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracturelast verified some time ago; the register no longer confirms its status-2021-01-11-
NCT03015220
Trial register
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetescompleted-2017-01-09Posted
NCT03061214
Trial register
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)completed-2017-02-23Posted
NCT03288740
Trial register
A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjectscompleted-2017-09-20-
NCT04383197
Trial register
Exercise and GLP-1 RA on Insulin Secretionlast verified some time ago; the register no longer confirms its status-2020-05-12-
NCT04109508
Trial register
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tabletscompleted-2019-09-30-
NCT04143945
Trial register
A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the completed-2019-10-30Posted
NCT03876015
Trial register
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)completed-2019-03-15-
NCT01923181
Trial register
Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetescompleted-2013-08-15Posted
NCT03018028
Trial register
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetescompleted-2017-01-11Posted
NCT03842202
Trial register
A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesitycompleted-2019-02-15-
NCT02773381
Trial register
A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensatiocompleted-2016-05-16-
NCT04238962
Trial register
A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Penscompleted-2020-01-23-
NCT04007107
Trial register
A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound forcompleted-2019-07-05Posted
NCT04447859
Trial register
16-week Flexible vs. 8-week Semaglutide Titrationlast verified some time ago; the register no longer confirms its status-2020-06-25-
NCT03724981
Trial register
A Study Comparing the Dulaglutide Pen and the Semaglutide Pencompleted-2018-10-30Posted
NCT02453711
Trial register
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellituscompleted-2015-05-25Posted
NCT03021187
Trial register
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulincompleted-2017-01-13Posted
NCT04175665
Trial register
Real-world Health Outcomes in Canadian Patients Using Semaglutidecompleted-2019-11-25-
NCT02070510
Trial register
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjectscompleted-2014-02-25-
NCT02249910
Trial register
Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjectscompleted-2014-09-26-
NCT02827708
Trial register
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairmentcompleted-2016-07-11Posted
NCT03136484
Trial register
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetescompleted-2017-05-02Posted
NCT03598621
Trial register
A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Toolscompleted-2018-07-26-
NCT03611322
Trial register
A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device andcompleted-2018-08-02-
NCT03638778
Trial register
Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Mencompleted-2018-08-20-
NCT04012255
Trial register
A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesityterminated before completion-2019-07-09-
NCT02648204
Trial register
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.completed-2016-01-06Posted
NCT03191396
Trial register
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetescompleted-2017-06-19Posted
NCT03707990
Trial register
A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obesecompleted-2018-10-16-
NCT04061200
Trial register
Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminurialast verified some time ago; the register no longer confirms its status-2019-08-19-
NCT00696657
Trial register
A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutidecompleted-2008-06-13Posted
NCT02461589
Trial register
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetescompleted-2015-06-03Posted
NCT01720446
Trial register
Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetescompleted-2012-11-02Posted
NCT03466567
Trial register
A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjectscompleted-2018-03-15-
NCT01885208
Trial register
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Dicompleted-2013-06-24Posted
NCT01930188
Trial register
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetescompleted-2013-08-28Posted
NCT02128932
Trial register
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjectscompleted-2014-05-01Posted
NCT02054897
Trial register
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetescompleted-2014-02-04Posted
NCT02305381
Trial register
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Tcompleted-2014-12-02Posted
NCT02877355
Trial register
Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.completed-2016-08-24-
NCT02207374
Trial register
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetescompleted-2014-08-04Posted
NCT01686945
Trial register
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Malecompleted-2012-09-18-
NCT02254291
Trial register
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetescompleted-2014-10-01Posted
NCT03659682
Trial register
GLP1R in Parkinson's Diseaselast verified some time ago; the register no longer confirms its status-2018-09-06-
NCT02147431
Trial register
A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetescompleted-2014-05-26-
NCT02249871
Trial register
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjectscompleted-2014-09-26-
NCT02064348
Trial register
A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjectscompleted-2014-02-17-
NCT02016911
Trial register
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairmentcompleted-2013-12-20-
NCT02014259
Trial register
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Functioncompleted-2013-12-18-
NCT02146079
Trial register
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjectscompleted-2014-05-23-
NCT02212067
Trial register
A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetescompleted-2014-08-08-
NCT02210871
Trial register
Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatcompleted-2014-08-07-
NCT03010475
Trial register
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjectscompleted-2017-01-05-
NCT02920385
Trial register
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokincompleted-2016-09-30-
NCT02079870
Trial register
Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obcompleted-2014-03-06-
NCT02845219
Trial register
A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in completed-2016-07-27-
NCT03144271
Trial register
Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjeccompleted-2017-05-08-
NCT00833716
Trial register
Effect of Renal Impairment on the Pharmacokinetics of NN9535completed-2009-02-02-
NCT02022254
Trial register
Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjectscompleted-2013-12-27-
NCT02243098
Trial register
Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjectscompleted-2014-09-17-
NCT02060266
Trial register
Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjectscompleted-2014-02-12-
NCT01572753
Trial register
Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjectscompleted-2012-04-06-
NCT01324505
Trial register
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetescompleted-2011-03-29-
NCT02557620
Trial register
Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weeklycompleted-2015-09-23-
NCT00813020
Trial register
A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjectscompleted-2008-12-22-
NCT00851773
Trial register
Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjectscompleted-2009-02-26-
NCT01272973
Trial register
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjectscompleted-2011-01-10-
NCT01619345
Trial register
Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjectscompleted-2012-06-14-
NCT02231684
Trial register
Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semacompleted-2014-09-04-
NCT02161588
Trial register
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjectscompleted-2014-06-11-
NCT02172313
Trial register
Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjectscompleted-2014-06-24-
NCT01766245
Trial register
A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of completed-2013-01-11-
NCT01866748
Trial register
Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in completed-2013-05-31-

Source: ClinicalTrials.gov and EU CTIS, read 2026-10-03. Not medical advice.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.